Follicle Development
The process by which primordial follicles in the ovary are recruited, grow, and either ovulate or undergo atresia (cell death) across the menstrual cycle. Each cycle, a cohort of follicles begins maturing under FSH stimulation. Typically one dominant follicle is selected, growing to 18 to 24 mm before the LH surge triggers ovulation. The remaining follicles in the cohort regress.
Clinicians monitor follicle development directly through a follicle maturation study. Serial transvaginal ultrasounds across the follicular phase show the growth rate, timing of dominant follicle selection, and whether ovulation actually occurs or the follicle fails to rupture. That last distinction matters: a follicle can luteinize without releasing the oocyte, a condition called LUF syndrome, which standard lab tests will not detect.
Inadequate follicle development has downstream consequences. A follicle that does not reach full maturity before ovulation produces a corpus luteum with reduced progesterone output. That sets up luteal phase deficiency even in a cycle that appeared ovulatory on a basal temperature chart. Treating the luteal phase problem without addressing the follicular phase problem leaves the root cause unresolved.
In RRM practice, ovulation induction agents (clomiphene, letrozole) are used when follicle development is inadequate, timed to the follicular phase based on chart data. Monitoring with serial ultrasound confirms the response and guides trigger decisions. The goal is to restore the follicle development pattern the body was not producing on its own.
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.